Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Regulatory News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £91.78m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

Suspension - Faron Pharmaceuticals Oy

30 Mar 2026 07:30

RNS Number : 5226Y
AIM
30 March 2026
 

NOTICE

 

30/03/2026 7:30am

 

TEMPORARY SUSPENSION OF TRADING ON AIM

 

FARON PHARMACEUTICALS OY

 

At the request of the Company, trading on AIM for the under-mentioned securities was temporarily suspended from 30/03/2026 7:30am, pending an announcement.

 

SUBSCRIPTION RIGHTS, NIL PAID (DI)

(BS84X55) (FI4000602313)

If you have any queries relating to the above, please contact the Company's nominated adviser on +44 (0) 207 213 0880.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
EXCJRMRTMTJTBIF
Date   Source Headline
27th Apr 20207:00 amRNSTraumakine to be a part of WHO’s Solidarity trial
23rd Apr 20201:00 pmRNSUpdate on results of Placing and issue of equity
22nd Apr 20207:00 amRNSResult of placing and issue price
21st Apr 20204:45 pmRNSProposed Placing
15th Apr 202011:06 amRNSSecond Price Monitoring Extn
15th Apr 202011:00 amRNSPrice Monitoring Extension
14th Apr 20207:00 amRNSNotice of Annual General Meeting
3rd Apr 20202:45 pmRNSAGM to be postponed
1st Apr 20207:00 amRNSREMAP-CAP to study IFN beta-1a effect in COVID-19
30th Mar 20207:00 amRNSPart 1 of the MATINS Phase I/II Study Completed
26th Mar 202010:00 amRNSCorrection to Faron´s Annual Report 2019
25th Mar 20207:28 amRNSFaron´s Annual Report 2019 published
20th Mar 202011:30 amRNSNotice of Annual General Meeting
20th Mar 20207:00 amRNSFinal Results for the year ended December 31, 2019
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20204:44 pmRNSSecond Price Monitoring Extn
12th Mar 20204:38 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSFDA accepts protocol for new Traumakine trial
5th Mar 20207:00 amRNSMATINS update
2nd Mar 20207:00 amRNSFaron to acquire AOC3 antagonist platform
26th Feb 20207:05 amRNSPrice Monitoring Extension
26th Feb 20207:01 amRNSSecond Price Monitoring Extn
26th Feb 20207:00 amRNSPrice Monitoring Extension
25th Feb 20202:05 pmRNSSecond Price Monitoring Extn
25th Feb 20202:00 pmRNSPrice Monitoring Extension
25th Feb 202011:00 amRNSPrice Monitoring Extension
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:35 pmRNSPrice Monitoring Extension
18th Feb 202011:06 amRNSSecond Price Monitoring Extn
18th Feb 202011:00 amRNSPrice Monitoring Extension
18th Feb 20209:05 amRNSSecond Price Monitoring Extn
18th Feb 20209:00 amRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTraumakine update
27th Jan 20207:00 amRNSOvarian cancer selected as 2nd MATINS trial cohort
13th Jan 20207:00 amRNSDMC approves colorectal cancer cohort expansion
30th Dec 20199:30 amRNSUpdate on Traumakine drug substance manufacturing
12th Dec 20192:00 pmRNSPrice Monitoring Extension
11th Dec 20197:00 amRNSMatins Trial Update
2nd Dec 20192:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20192:00 pmRNSPrice Monitoring Extension
29th Nov 20192:05 pmRNSSecond Price Monitoring Extn
29th Nov 20192:00 pmRNSPrice Monitoring Extension
29th Nov 20197:31 amRNSLIQUIDITY PROVIDING AGREEMENT
29th Nov 20197:30 amRNSCompany Description & information on cash position
28th Nov 20199:05 amRNSSecond Price Monitoring Extn
28th Nov 20199:00 amRNSPrice Monitoring Extension
28th Nov 20197:00 amRNSFDA has approved Faron's Clevegen IND
27th Nov 20194:00 pmRNSFaron´s financial calendar for 2020
21st Nov 20192:00 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.